| Acute treatment (n = 46) | Follow-up care (n = 84) |
---|---|---|
Children | ||
 Gender (n, %) |  |  |
  Male | 17 (37.0) | 53 (63.1) |
  Female | 29 (63.0) | 31 (36.9) |
  Diverse | 0 (0.0) | 0 (0.0) |
 Age (M, SD) | 10.6 (3.8) | 12.6 (3.3) |
 Diagnosis (n, %) |  |  |
  Leukaemia | 15 (32.6) | 32 (38.1) |
  Lymphoma | 7 (15.2) | 10 (11.9) |
  Tumour of the central nervous system | 8 (17.4) | 24 (28.6) |
  Other solid tumour†| 16 (34.8) | 18 (21.4) |
 Time since diagnosis in months (M, SD) | 7.6 (17.4) | 79.7 (44.0) |
 Treatment modality (n, %—multiple responses possible) |  |  |
  Chemotherapy | 41 (89.1) | 73 (86.9) |
  Radiotherapy | 7 (15.2) | 21 (25.0) |
  Surgical measures | 21 (45.7) | 37 (44.0) |
  Haematopoietic stem cell transplant | 1 (2.2) | 8 (9.5) |
  Other‡ | 0 (0.0) | 5 (5.9) |
 Combination of treatment modalities |  |  |
  Unimodal | 27 (58.7) | 46 (54.8) |
  Multimodal (more than one modality) | 19 (41.3) | 38 (45.2) |
Parent | ||
 Participating parent (n, %) |  |  |
  Mother | 40 (87.0) | 69 (82.1) |
  Father | 6 (13.0) | 15 (17.9) |
 Age (M, SD) | 38.3 (5.8) | 42.7 (6.1) |